drugset / Trial / NCT01552863

A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers

NCT01552863

Phase 1 Completed 21 enrolled Pain Therapeutics
RandomizedCrossoverOpen-labelBasic science

Summary

This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 6- dosing period study to characterize the pharmacokinetics of oxycodone (process by which oxycodone is absorbed, distributed, metabolized, and eliminated by the body). This study will consist of three parts that will take place over approximately 90 days. Part 1 of the study has 4 dosing periods, while Parts 2 and 3 have one dosing period each.

Timeline

Start
2012-03
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 5 mg Oral
Subject Oxycodone Other / unclassified 40 mg Oral

Indications

No indication recorded.